119 web-programmer-developer-"https:" "https:" "https:" "https:" "University of Southampton" Fellowship positions at Zintellect
Sort by
Refine Your Search
-
mycobateria and brucella families in various species of animals using serological tests as part of the eradication program. Learning Objectives: The participant will have the opportunity to learn about zoonotic
-
, they will practice sampling gas wells and prepare samples for laboratory analysis to evaluate carbon storage and respiration rates within the root zone. Post-Fire Geochemical and Microbiological Vadose Zone
-
plant pathogen that causes soybean red leaf blotch. You will help collect and analyze whole genome sequence data, develop fungal transformation protocols, and utilize other molecular tools to identify and
-
and gene therapy. You will use advanced manufacturing tools and strategies to gain a deeper understanding of challenges associated with T cell-based immunotherapies such as CAR-T cells and develop novel
-
and gene therapies. Research Project: You will join a research program that broadly investigates unwanted immune responses to proteins used in therapeutic applications. The specific focus will be immune
-
and gene therapies. Research Project: You will join a research program that: (i) Investigates the mechanism(s) of coagulation in the context of drugs used to treat bleeding disorders. (ii) Develops
-
discoveries through scientific excellence. Research Project: Research will focus on development of bioinformatics and genomics tools to characterize the structure and function of the bovine genome and then
-
and gene therapy. You will use advanced manufacturing tools and strategies to gain a deeper understanding of challenges associated with T cell-based immunotherapies such as CAR-T cells and develop novel
-
-products into value-added food ingredients and enhance their functional, nutritional, and sensory properties through fermentation technologies. The long-term vision is to enable the development of health
-
responses. While most patients tolerate therapeutic products without issue, a subset develops immune-mediated adverse reactions, often driven by interactions between drug-derived or altered epitopes and the